BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 36991484)

  • 1. Bioinformatics screening of colorectal-cancer causing molecular signatures through gene expression profiles to discover therapeutic targets and candidate agents.
    Horaira MA; Islam MA; Kibria MK; Alam MJ; Kabir SR; Mollah MNH
    BMC Med Genomics; 2023 Mar; 16(1):64. PubMed ID: 36991484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression profile analysis to discover molecular signatures for early diagnosis and therapies of triple-negative breast cancer.
    Alam MS; Sultana A; Wang G; Haque Mollah MN
    Front Mol Biosci; 2022; 9():1049741. PubMed ID: 36567949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinformatics Screening of Potential Biomarkers from mRNA Expression Profiles to Discover Drug Targets and Agents for Cervical Cancer.
    Reza MS; Harun-Or-Roshid M; Islam MA; Hossen MA; Hossain MT; Feng S; Xi W; Mollah MNH; Wei Y
    Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of host transcriptome-guided repurposable drugs for SARS-CoV-1 infections and their validation with SARS-CoV-2 infections by using the integrated bioinformatics approaches.
    Ahmed FF; Reza MS; Sarker MS; Islam MS; Mosharaf MP; Hasan S; Mollah MNH
    PLoS One; 2022; 17(4):e0266124. PubMed ID: 35390032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Robust identification of common genomic biomarkers from multiple gene expression profiles for the prognosis, diagnosis, and therapies of pancreatic cancer.
    Hossen MB; Islam MA; Reza MS; Kibria MK; Horaira MA; Tuly KF; Faruqe MO; Kabir F; Mollah MNH
    Comput Biol Med; 2023 Jan; 152():106411. PubMed ID: 36502691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatics and network-based screening and discovery of potential molecular targets and small molecular drugs for breast cancer.
    Alam MS; Sultana A; Sun H; Wu J; Guo F; Li Q; Ren H; Hao Z; Zhang Y; Wang G
    Front Pharmacol; 2022; 13():942126. PubMed ID: 36204232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring Core Genes by Comparative Transcriptomics Analysis for Early Diagnosis, Prognosis, and Therapies of Colorectal Cancer.
    Islam MA; Hossen MB; Horaira MA; Hossen MA; Kibria MK; Reza MS; Tuly KF; Faruqe MO; Kabir F; Mahumud RA; Mollah MNH
    Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Employing bioinformatics analysis to identify hub genes and microRNAs involved in colorectal cancer.
    Ebadfardzadeh J; Kazemi M; Aghazadeh A; Rezaei M; Shirvaliloo M; Sheervalilou R
    Med Oncol; 2021 Aug; 38(9):114. PubMed ID: 34390411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Prognostic Biomarker Signatures and Candidate Drugs in Colorectal Cancer: Insights from Systems Biology Analysis.
    Rahman MR; Islam T; Gov E; Turanli B; Gulfidan G; Shahjaman M; Banu NA; Mollah MNH; Arga KY; Moni MA
    Medicina (Kaunas); 2019 Jan; 55(1):. PubMed ID: 30658502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Drug Targets and Agents Associated with Hepatocellular Carcinoma through Integrated Bioinformatics Analysis.
    Hossen MA; Reza MS; Harun-Or-Roshid M; Islam MA; Siddika MA; Mollah MNH
    Curr Cancer Drug Targets; 2023; 23(7):547-563. PubMed ID: 36786134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-cell RNA-seq analysis to identify potential biomarkers for diagnosis, and prognosis of non-small cell lung cancer by using comprehensive bioinformatics approaches.
    Sultana A; Alam MS; Liu X; Sharma R; Singla RK; Gundamaraju R; Shen B
    Transl Oncol; 2023 Jan; 27():101571. PubMed ID: 36401966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-transcriptome analysis reveals a potential hsa_circ_0001955/hsa_circ_0000977-mediated miRNA-mRNA regulatory sub-network in colorectal cancer.
    Ding B; Yao M; Fan W; Lou W
    Aging (Albany NY); 2020 Mar; 12(6):5259-5279. PubMed ID: 32221048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated bioinformatics and statistical approaches to explore molecular biomarkers for breast cancer diagnosis, prognosis and therapies.
    Alam MS; Sultana A; Reza MS; Amanullah M; Kabir SR; Mollah MNH
    PLoS One; 2022; 17(5):e0268967. PubMed ID: 35617355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statistics and network-based approaches to identify molecular mechanisms that drive the progression of breast cancer.
    Alam MS; Rahaman MM; Sultana A; Wang G; Mollah MNH
    Comput Biol Med; 2022 Jun; 145():105508. PubMed ID: 35447458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Hub Genes for Colorectal Cancer with Liver Metastasis Using miRNA-mRNA Network.
    Zhang SM; Shen C; Li J; Wang XD; Zhai SQ; Shi LL; Lu DL; Jiang XH; Qiu J
    Dis Markers; 2023; 2023():2295788. PubMed ID: 36798788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three hematologic/immune system-specific expressed genes are considered as the potential biomarkers for the diagnosis of early rheumatoid arthritis through bioinformatics analysis.
    Cheng Q; Chen X; Wu H; Du Y
    J Transl Med; 2021 Jan; 19(1):18. PubMed ID: 33407587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the differential expression of genes and upstream microRNAs in small cell lung cancer compared with normal lung based on bioinformatics analysis.
    Li X; Ma C; Luo H; Zhang J; Wang J; Guo H
    Medicine (Baltimore); 2020 Mar; 99(11):e19086. PubMed ID: 32176034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of genetic biomarkers, drug targets and agents for respiratory diseases utilising integrated bioinformatics approaches.
    Ahmed FF; Das AD; Sumi MJ; Islam MZ; Rahman MS; Rashid MH; Alyami SA; Alotaibi N; Azad AKM; Moni MA
    Sci Rep; 2023 Nov; 13(1):19072. PubMed ID: 37925496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental validation of in silico analysis estimated the reverse effect of upregulated hsa-miR-106a-5p and hsa-miR-223-3p on SLC4A4 gene expression in Iranian patients with colorectal adenocarcinoma by RT-qPCR.
    Ranjbaran J; Safarpour H; Nomiri S; Tavakoli T; Rezaei Z; Salmani F; Larki P; Chamani E
    Cancer Med; 2023 Mar; 12(6):7005-7018. PubMed ID: 36468451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Network-Based Data Analysis Reveals Ion Channel-Related Gene Features in COVID-19: A Bioinformatic Approach.
    Zhang H; Feng T
    Biochem Genet; 2023 Apr; 61(2):471-505. PubMed ID: 36104591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.